These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23871798)

  • 1. Treatment of mucosal leishmaniasis (L. infantum) with miltefosine in a patient with Good syndrome.
    Stoeckle M; Holbro A; Arnold A; Neumayr A; Weisser M; Blum J
    Acta Trop; 2013 Oct; 128(1):168-70. PubMed ID: 23871798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal Leishmania infantum infection.
    Richter J; Hanus I; Häussinger D; Löscher T; Harms G
    Parasitol Res; 2011 Sep; 109(3):959-62. PubMed ID: 21499751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal leishmaniasis and miltefosine.
    Tuon FF; Amato VS
    Clin Infect Dis; 2007 Jun; 44(11):1525-6; author reply 1526-7. PubMed ID: 17479959
    [No Abstract]   [Full Text] [Related]  

  • 4. Localized mucosal leishmaniasis due to Leishmania (Leishmania) infantum: clinical and microbiologic findings in 31 patients.
    Aliaga L; Cobo F; Mediavilla JD; Bravo J; Osuna A; Amador JM; Martín-Sánchez J; Cordero E; Navarro JM
    Medicine (Baltimore); 2003 May; 82(3):147-58. PubMed ID: 12792301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment.
    Calvopina M; Gomez EA; Sindermann H; Cooper PJ; Hashiguchi Y
    Am J Trop Med Hyg; 2006 Dec; 75(6):1074-7. PubMed ID: 17172368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial use of pentamidine and miltefosine for treating Leishmania infantum-HIV coinfection.
    Faucher JF; Morquin D; Reynes J; Chirouze C; Hoen B; Le Moing V
    Parasitol Int; 2016 Oct; 65(5 Pt A):444-6. PubMed ID: 27353022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of extended (six weeks) treatment with miltefosine for mucosal leishmaniasis in Bolivia.
    Soto J; Rea J; Valderrama M; Toledo J; Valda L; Ardiles J; Berman J
    Am J Trop Med Hyg; 2009 Sep; 81(3):387-9. PubMed ID: 19706901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of imported mucosal Leishmania infantum leishmaniasis with miltefosine after severe hypokalemia under meglumine antimoniate treatment.
    Neumayr AL; Walter C; Stoeckle M; Braendle N; Glatz K; Blum JA
    J Travel Med; 2012; 19(2):124-6. PubMed ID: 22414039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with miltefosine for persistent or relapsing visceral leishmaniasis in solid organ transplant recipients: A case series from Spain.
    Pérez-Jacoiste Asín MA; Carrasco-Antón N; Fernández-Ruiz M; San Juan R; Alonso-Moralejo R; González E; Andrés A; López-Medrano F; Aguado JM
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27768239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendations.
    Monge-Maillo B; López-Vélez R
    Clin Infect Dis; 2015 May; 60(9):1398-404. PubMed ID: 25601455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complex cutaneous leishmaniasis with bone involvement].
    Hübner GA; Prüßmann W; Jossifov N; Mischnik A; Terheyden P
    Dermatologie (Heidelb); 2024 Aug; 75(8):647-652. PubMed ID: 38916602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Report: Successful Treatment with Miltefosine of Severe New World Mucosal Leishmaniasis Caused by
    Calvopina M; Jijon S; Serrano E; Kato H
    Am J Trop Med Hyg; 2020 Aug; 103(2):752-755. PubMed ID: 32524951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Miltefosine for new world cutaneous leishmaniasis.
    Soto J; Arana BA; Toledo J; Rizzo N; Vega JC; Diaz A; Luz M; Gutierrez P; Arboleda M; Berman JD; Junge K; Engel J; Sindermann H
    Clin Infect Dis; 2004 May; 38(9):1266-72. PubMed ID: 15127339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of parasite clearance in cutaneous leishmaniasis patients treated with miltefosine.
    Dorlo TP; van Thiel PP; Schoone GJ; Stienstra Y; van Vugt M; Beijnen JH; de Vries PJ
    PLoS Negl Trop Dis; 2011 Dec; 5(12):e1436. PubMed ID: 22180803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histological spectrum of non-granulomatous localized mucosal leishmaniasis caused by Leishmania infantum.
    Cobo F; Aliaga L; Talavera P; Concha A
    Ann Trop Med Parasitol; 2007 Dec; 101(8):689-94. PubMed ID: 18028730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Miltefosine versus meglumine antimoniate in the treatment of mucosal leishmaniasis].
    Garcia Bustos MF; Barrio A; Parodi C; Beckar J; Moreno S; Basombrio MA
    Medicina (B Aires); 2014; 74(5):371-7. PubMed ID: 25347898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights with miltefosine unresponsiveness in Brazilian Leishmania infantum isolates.
    Bhattacharya A; Ouellette M
    EBioMedicine; 2018 Nov; 37():13-14. PubMed ID: 30314891
    [No Abstract]   [Full Text] [Related]  

  • 18. Co-infection of mucosal leishmaniasis and extra pulmonary tuberculosis in a patient with inherent immune deficiency.
    Rathnayake D; Ranawake RR; Sirimanna G; Siriwardhane Y; Karunaweera N; De Silva R
    Int J Dermatol; 2010 May; 49(5):549-51. PubMed ID: 20534090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.
    Manna L; Vitale F; Reale S; Picillo E; Neglia G; Vescio F; Gravino AE
    Vet J; 2009 Dec; 182(3):441-5. PubMed ID: 18818112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1.
    Schraner C; Hasse B; Hasse U; Baumann D; Faeh A; Burg G; Grimm F; Mathis A; Weber R; Günthard HF
    Clin Infect Dis; 2005 Jun; 40(12):e120-4. PubMed ID: 15909255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.